SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs WellDoc BlueStar

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

by DIACOUSTIC MEDICAL DEVICES (PTY)

WellDoc BlueStar

by WellDoc

AI Verdict

Tool A is a clinical decision support tool for physicians, specifically designed to aid in the diagnosis of heart murmurs by analyzing acoustic signals. In contrast, Tool B is a patient-facing digital health solution focused on chronic disease management, offering personalized coaching and insights for conditions like diabetes, hypertension, and heart failure. While both leverage AI in the cardiology space, Tool A targets diagnostic assistance for clinicians, whereas Tool B focuses on ongoing patient engagement and self-management across multiple cardiometabolic conditions.

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if your clinical practice requires an AI-powered mobile solution to assist in the real-time diagnosis and differentiation of heart murmurs. This tool is ideal for physicians in cardiology, internal medicine, or pediatrics who need decision support to analyze acoustic heart signals captured via an electronic stethoscope, helping to distinguish between physiological and pathological sounds at the point of care.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Choose WellDoc BlueStar if…

Choose WellDoc BlueStar if you are a health plan, health system, or employer seeking an FDA-cleared, AI-powered digital health solution to empower patients with chronic conditions like diabetes, hypertension, and heart failure. This platform provides personalized coaching, integrates with various connected devices, and offers valuable insights and remote monitoring capabilities to support long-term patient self-management and improve cardiometabolic care outcomes.

View WellDoc BlueStar →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	WellDoc BlueStar
Pricing	Contact for pricing	Enterprise pricing; paid by health plans, health systems, or employers.
Deployment	Hosted server environment (Linux OS) with a mobile application interface	Mobile app (iOS, Android) and web-based platform
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

WellDoc BlueStar

WellDoc BlueStar offers a broader, multi-platform approach (mobile and web) and integrates with a wide array of connected patient devices, making it highly accessible for its target users (patients and care teams). SensiCardiac Mobi is a specialized diagnostic tool for physicians, requiring specific hardware, which limits its general usability compared to WellDoc's comprehensive patient-facing solution.

Clinical Value

WellDoc BlueStar

Both tools are FDA-cleared and provide significant clinical value in their respective areas. However, WellDoc BlueStar's multi-condition support for chronic diseases, including personalized coaching and specific features like insulin dose recommendations, offers a broader and potentially more sustained impact on long-term patient health outcomes across a wider patient population.

Pricing & Value

Tie

Both tools utilize an enterprise pricing model and require direct contact for details, making their pricing opaque to the public. Without specific cost information for either product, it is impossible to conduct a meaningful comparison of their pricing or assess which offers better value.

Enterprise Readiness

WellDoc BlueStar

Both are FDA-cleared, HIPAA compliant, and have BAAs, indicating strong foundational readiness. WellDoc BlueStar explicitly highlights enterprise pricing, a dedicated 'Care team portal for providers,' and 'SMARTVisit reports,' demonstrating a more comprehensive suite of features designed for large-scale deployment and integration into existing healthcare enterprise workflows.

Innovation

WellDoc BlueStar

Both tools leverage AI innovatively. SensiCardiac Mobi's innovation is in its specialized AI for acoustic heart murmur diagnosis. WellDoc BlueStar, however, demonstrates broader innovation through its comprehensive, personalized, multi-condition chronic care management, integrating data from numerous connected devices and providing advanced actionable recommendations like insulin dosing.

Support & Docs

WellDoc BlueStar

WellDoc BlueStar provides clear and accessible customer care information, including a dedicated phone number, operating hours, and specific support areas. SensiCardiac Mobi offers user manuals and mentions installation videos, but lacks similarly explicit and readily available direct customer support channels.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	WellDoc BlueStar
Primary Use Case	Assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope to differentiate between physiological and pathological sounds.	AI-powered digital health solution for chronic disease management, offering personalized coaching and insights for conditions like diabetes, hypertension, and heart failure.
Company	DIACOUSTIC MEDICAL DEVICES (PTY)	WellDoc
Primary Categories	Cardiology AI, Clinical Decision Support & Reference	Cardiology AI, Endocrinology & Metabolic AI, Patient Engagement & Education
Core Diagnostic/Management Feature	Analyzes heart sounds using the Sensi Diagnostic Heart Murmur Algorithm to distinguish between normal/physiological and pathological heart murmurs.	AI-driven personalized coaching and insights for chronic disease management.
Specific Functionality/Support	Records heart sounds at four main auscultation positions and identifies S1, S2, and suspected murmurs.	Multi-condition support (diabetes, hypertension, heart failure, weight management, behavioral health) and integration with connected devices.

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION and WellDoc BlueStar.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How does each tool integrate into a physician's existing clinical workflow for patient assessment and ongoing management?

SensiCardiac Mobi functions as a decision support tool during in-office auscultation, assisting physicians by analyzing acoustic heart signals from an electronic stethoscope to differentiate heart murmurs. WellDoc BlueStar supports ongoing chronic disease management by providing personalized coaching and insights directly to patients, while offering a care team portal and SMARTVisit reports for providers to monitor and manage patient data between visits.

What level of integration with existing Electronic Health Record (EHR) systems can physicians expect from each tool, particularly for data transfer and documentation?

WellDoc BlueStar offers deep EMR and workflow integration, including bidirectional data exchange and access to real-time patient insights via Smart Visit Reports within the EHR, facilitated by partnerships with platforms like Xealth and Redox. SensiCardiac Mobi's description does not explicitly detail its EHR integration capabilities, so direct inquiry would be necessary.

What specific clinical evidence or performance metrics are available to demonstrate the diagnostic accuracy of SensiCardiac Mobi and the clinical efficacy of WellDoc BlueStar in their respective applications?

SensiCardiac Mobi, utilizing the Sensi Diagnostic Heart Murmur Algorithm, has reported accuracy above 95% for murmur detection, with a virtual clinical trial showing 93% sensitivity and 81% specificity for pathologic cases. WellDoc BlueStar is backed by over 75 clinical publications and randomized controlled trials, demonstrating a 1.7 to 2.0-point mean A1C reduction for type 2 diabetes, along with improvements in blood pressure and weight loss.

For which specific patient populations and clinical scenarios is each tool most appropriately utilized, given their distinct functionalities?

SensiCardiac Mobi is primarily suited for cardiologists, internal medicine physicians, and pediatricians who require diagnostic assistance in differentiating heart murmurs during patient examinations. WellDoc BlueStar is designed for patients managing chronic conditions such as diabetes, hypertension, and heart failure, providing ongoing support and insights for specialists in cardiology, endocrinology, and internal medicine.

What is the expected learning curve for physicians and their staff to effectively use each tool, and what is the typical time-to-value for seeing clinical benefits?

SensiCardiac Mobi, as a mobile application for diagnostic support with an electronic stethoscope, appears to have a relatively straightforward learning curve, with reported high usability. WellDoc BlueStar, while comprehensive with multi-condition support and device integrations, aims to streamline provider workflows through its care team portal and actionable insights, contributing to clinical benefits over time.

What considerations should be taken into account for deploying and managing either tool across multiple clinic sites or a larger healthcare system?

WellDoc BlueStar is designed for enterprise deployment at a system level, with a scalable architecture that supports managing large patient populations across multiple chronic disease states and has been evaluated for effectiveness at scale. SensiCardiac Mobi, operating with a hosted server and mobile application, also suggests a scalable model for diagnostic support across various clinical settings.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION or WellDoc BlueStar

Backers

Who funded each tool's parent company.